201 related articles for article (PubMed ID: 20144859)
21. Rapid scale up of harm reduction in China.
Sullivan SG; Wu Z
Int J Drug Policy; 2007 Mar; 18(2):118-28. PubMed ID: 17689354
[TBL] [Abstract][Full Text] [Related]
22. Needle syringe acquisition and HIV prevention among injecting drug users: a treatise on the "good" and "not so good" public health practices in South Asia.
Panda S; Sharma M
Subst Use Misuse; 2006; 41(6-7):953-77. PubMed ID: 16809181
[TBL] [Abstract][Full Text] [Related]
23. Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth.
Stone KA
Harm Reduct J; 2015 Oct; 12():32. PubMed ID: 26472335
[TBL] [Abstract][Full Text] [Related]
24. Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme.
Islam MM; Conigrave KM
Drug Alcohol Rev; 2007 Jul; 26(4):445-54. PubMed ID: 17564883
[TBL] [Abstract][Full Text] [Related]
25. Advocacy for harm reduction in China: a new era dawns.
Reid G; Aitken C
Int J Drug Policy; 2009 Jul; 20(4):365-70. PubMed ID: 19097773
[TBL] [Abstract][Full Text] [Related]
26. Scaling up HIV prevention efforts targeting people who inject drugs in Central Asia: a review of key challenges and ways forward.
Boltaev AA; El-Bassel N; Deryabina AP; Terlikbaeva A; Gilbert L; Hunt T; Primbetova S; Strathdee SA
Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S41-7. PubMed ID: 24103128
[TBL] [Abstract][Full Text] [Related]
27. Implementing harm reduction for heroin users in Afghanistan, the worldwide opium supplier.
Maguet O; Majeed M
Int J Drug Policy; 2010 Mar; 21(2):119-21. PubMed ID: 20171864
[TBL] [Abstract][Full Text] [Related]
28. Estimating resource needs for HIV/AIDS health care services in low-income and middle-income countries.
Bertozzi S; Gutierrez JP; Opuni M; Walker N; Schwartländer B
Health Policy; 2004 Aug; 69(2):189-200. PubMed ID: 15212866
[TBL] [Abstract][Full Text] [Related]
29. Late for the epidemic: HIV/AIDS in Eastern Europe.
Cohen J
Science; 2010 Jul; 329(5988):160, 162-4. PubMed ID: 20616262
[No Abstract] [Full Text] [Related]
30. The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine.
Vickerman P; Kumaranayake L; Balakireva O; Guinness L; Artyukh O; Semikop T; Yaremenko O; Watts C
Sex Transm Dis; 2006 Oct; 33(10 Suppl):S89-102. PubMed ID: 16735956
[TBL] [Abstract][Full Text] [Related]
31. The role and development of the Asian Harm Reduction Network.
Tanguay PF; Smits T
Int J Drug Policy; 2007 Mar; 18(2):148-51. PubMed ID: 17689359
[TBL] [Abstract][Full Text] [Related]
32. Legal harm reduction among intravenous drug users.
Kongsakon R; Pocham N
J Med Assoc Thai; 2006 Sep; 89(9):1545-50. PubMed ID: 17100399
[TBL] [Abstract][Full Text] [Related]
33. Inequalities in health: access to treatment for HIV/AIDS.
Giuliano M; Vella S
Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264
[TBL] [Abstract][Full Text] [Related]
34. International response to the HIV/AIDS epidemic: planning for success.
Piot P; Coll Seck AM
Bull World Health Organ; 2001; 79(12):1106-12. PubMed ID: 11799442
[TBL] [Abstract][Full Text] [Related]
35. The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002-2014).
Bridge J; Hunter BM; Albers E; Cook C; Guarinieri M; Lazarus JV; MacAllister J; McLean S; Wolfe D
Int J Drug Policy; 2016 Jan; 27():132-7. PubMed ID: 26342275
[TBL] [Abstract][Full Text] [Related]
36. Harm reduction--from a conceptual framework to practical experience: the example of Germany.
Michels II; Stöver H
Subst Use Misuse; 2012; 47(8-9):910-22. PubMed ID: 22676562
[TBL] [Abstract][Full Text] [Related]
37. When the dragon's awake: a needs assessment of people injecting drugs in a small urban centre.
Gustafson DL; Goodyear L; Keough F
Int J Drug Policy; 2008 Jun; 19(3):189-94. PubMed ID: 18472260
[TBL] [Abstract][Full Text] [Related]
38. Estimating the resource needs of scaling-up HIV/AIDS and tuberculosis interventions in sub-Saharan Africa: a systematic review for national policy makers and planners.
Vassall A; Compernolle P
Health Policy; 2006 Nov; 79(1):1-15. PubMed ID: 16388874
[TBL] [Abstract][Full Text] [Related]
39. Implementation of harm reduction in Central and Eastern Europe and Central Asia.
Sarang A; Stuikyte R; Bykov R
Int J Drug Policy; 2007 Mar; 18(2):129-35. PubMed ID: 17689355
[TBL] [Abstract][Full Text] [Related]
40. Ryan White CARE Act Title IV programs: a preliminary characterization of benefits and costs.
Abramowitz S; Greene D
AIDS Public Policy J; 2005; 20(3-4):108-25. PubMed ID: 17624034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
